SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095403
Filing Date
2024-08-12
Accepted
2024-08-12 16:05:21
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-20240630.htm   iXBRL 10-Q 1422797
2 EX-31.1 svra-ex31_1.htm EX-31.1 14634
3 EX-31.2 svra-ex31_2.htm EX-31.2 14635
4 EX-32.1 svra-ex32_1.htm EX-32.1 11117
5 GRAPHIC img199014270_0.jpg GRAPHIC 3968
  Complete submission text file 0000950170-24-095403.txt   6643601

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20240630.xsd EX-101.SCH 1040430
70 EXTRACTED XBRL INSTANCE DOCUMENT svra-20240630_htm.xml XML 1116283
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 241196726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)